Skip to main content
Sisram Medical Ltd logo

Sisram Medical Ltd — Investor Relations & Filings

Ticker · 1696 ISIN · IL0011418113 HKEX Manufacturing
Open in API
Filings indexed 1,569 across all filing types
Latest filing 2023-02-02 Regulatory Filings
Country HK Hong Kong
Listing HKEX 1696

About Sisram Medical Ltd

http://www.sisram-medical.com

Sisram Medical Ltd. is a global consumer wellness group specializing in medical aesthetics and minimally invasive solutions. Leveraging over two decades of expertise, the company is a leader in Energy-Based Devices (EBD), harnessing natural energy sources for both aesthetic and medical clinical indications. Sisram operates through a synergistic ecosystem of brands, providing medical-grade quality solutions to professional customers and consumers worldwide. Key segments include Alma, a provider of energy-based solutions for surgical and medical aesthetics markets; LMNT, a personal care brand for home use; Copulla, which offers end-to-end digital dentistry services; and a dedicated injectables portfolio. The company's extensive product range covers treatments such as hair removal, skin rejuvenation, body contouring, and dermal fillers.

Recent filings

Filing Released Lang Actions
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
Regulatory Filings Classification · 95% confidence The document is a monthly return detailing movements in securities, specifically authorized and issued shares, for Sisram Medical Ltd as submitted to the Hong Kong Exchanges and Clearing Limited. It includes data on share capital, issued shares, and confirms no changes in share options, warrants, convertibles, or other agreements. The document is a regulatory submission reporting share capital and share issuance movements for the month ended January 31, 2023. It is not a full financial report, earnings release, or management discussion. It is also not a proxy, AGM material, or legal proceeding. The document fits the category of a regulatory announcement related to share capital and securities movements under exchange listing rules, which aligns best with Regulatory Filings (RNS) as a general category for such compliance and disclosure documents that do not fit other specific categories. The document length is under 5,000 characters, and it is a direct submission rather than an announcement of a report publication, so RPA is not appropriate. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2023-02-02 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2022
Regulatory Filings Classification · 95% confidence The document is a detailed monthly return regarding movements in securities, specifically focusing on authorized and issued share capital, share options, convertibles, and confirmations related to securities issued by Reliance Global Holdings Limited. It is addressed to the Hong Kong Exchanges and Clearing Limited and references compliance with the Exchange Listing Rules. The document does not contain financial statements or management discussion but is a regulatory submission about share capital movements and confirmations. It is not an annual or interim report, earnings release, or management report. It is a regulatory filing related to share capital movements and confirmations under listing rules, which fits best under the category of Regulatory Filings (RNS).
2023-01-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
Regulatory Filings Classification · 95% confidence The document is a monthly return report detailing movements in securities, specifically authorized and issued shares, for Sisram Medical Ltd as of December 31, 2022. It is addressed to the Hong Kong Exchanges and Clearing Limited and follows a standard form (FF301) used for reporting share capital and share movements under Chapter 19B of the Exchange Listing Rules. The document does not contain financial statements, management discussion, or earnings data. It is a regulatory submission focused on share capital and share issuance status rather than a financial report or announcement of voting results. Given the nature of the content and the regulatory context, this document fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory reports that do not fit other specific categories.
2023-01-04 English
REVISED FORM OF PROXY FOR THE EXTRAORDINARY GENERAL MEETING ON THURSDAY, FEBRUARY 9, 2023
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a revised form of proxy for an Extraordinary General Meeting (EGM) of Sisram Medical Ltd. It includes instructions for shareholders to appoint proxies and vote on resolutions, specifically regarding a sublicense agreement. The content is procedural and related to voting at a shareholder meeting, not a report or announcement of financial results or management changes. It is not an AGM Information document because it is for an EGM, and it is not a Declaration of Voting Results since it does not provide voting outcomes. The document is best classified as Proxy Solicitation & Information Statement (PSI), as it is a form sent to shareholders to provide information and request votes for the meeting.
2023-01-03 English
LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS
Board/Management Information Classification · 100% confidence The document lists the members of the board of directors and their roles and functions, including committee memberships, effective from January 1, 2023. It is an announcement related to the company's board composition and governance structure. There is no financial data, no report or presentation content, and no mention of voting results or other types of filings. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management. The document is short and focused solely on board composition, confirming the classification.
2022-12-29 English
RESIGNATION OF EXECUTIVE DIRECTOR
Board/Management Information Classification · 100% confidence The document is an announcement from Sisram Medical Ltd regarding the resignation of an executive director and chief financial officer. It details the resignation effective date, confirms no disagreements, and expresses gratitude. There is no financial data, no report attached or referenced, and no mention of any other type of filing such as annual reports, earnings, or regulatory certifications. This fits the category of Board/Management Information (MANG), which covers announcements of changes in the company's board of directors or senior management.
2022-12-29 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.